Healthtronics Inc

Healthtronics — Investor Presentation (March 2010)

22 slides from Healthtronics's investor presentation, Mar 23, 2010

  1. Slide 1: HealthTronics

    E_ YY 7 HealthTronics

  2. Slide 2: Corporate Overview

    HealthtTroni Corporate Overview * Leading Provider of Urology Services in the U.S. * Market leaders in Lithotripsy, BPH Laser and Cryosurgery * Goal to become urologic market leader in: — Anatomic Pathology —Radiation Therapy * Unique Business Relationship with Approximately One-Third of Urologists

  3. Slide 3: Total Solution for Urology Marketplace

    HealthTronicss | — Total Solution for Urology Marketplace TOTALCARE VapY Business Development Ops& Scheduling ‘Compliance & Regulatory Legal & Contracting Enabling Technologies Improve patient care Accounting Enhance practice economics Staffing & Certification isk Service & Mitigation Maintenance

  4. Slide 4: Stabilization of the Base Business

    HealthTronicss | Stabilization of the Base Business 2005 2006 2007 ______ 2008 z= ere June 2106 — Specially Vehicles Divested a ee rcensiascatea wil porimces James Whitenburg named President of Ssaeaadel any ease Urology services 2007 and 2008 —Partnershap revenue and > Older partnerships still with

  5. Slide 5: HealthTronics Competitive Position

    am) 2 . HealthTronics —£ = as HealthTronics Competitive Position + Relationships with one-third of all urologjsts in the nation + Health Tronics is a critical partner, co-investor, technology advisor and advocate + Health Tronics is viewed as the most influential national player in the Urology Servi

  6. Slide 6: Radiation Therapy

    Radiation Therapy i oreal Shiork Wave: Lahouipsy. TBPH Laser + Cancer centers with IGRT deployed + Deployed in partnership with invested + Cryoablation a. Anatomic Pathology Devices, Maintenance and Consumables cHmomang oreo ye sharing network acne: z + BPH Laser and Cryocare me oe noes = Equipment

  7. Slide 7: HealthTronics Value Proposition

    <1 HealthTronicss | HealthTronics Value Proposition a Urologists ° Shared financial, operational and ° Accesso quality healthcare obsolescence risk > Ti of and jurnicey platform of products L : . * Urologists canfocus on patient ), Improves Practice | options Economics ~~] * Access to latest technol

  8. Slide 8: Equity-Based Partnership Model

    Equity-Based Partnership Model HealthTronics employs a successful lithotripsy partnership model ‘On average, 80%/20% physician/Health Tronics equity split in its partnerships Health Tronics shares in the initial capital investment Partnership profits distributed to equity hoklersbased on % ownership

  9. Slide 9: Kidney Stone and BPH Market Data

    Oo HealthTronicss Kidney Stone and BPH Market Data set Indication Market + Kidney Stones ° Extracorporeal Shock Wave Lithotripsy Services — Stones are hard masses that form arpwherein — Extracorporeal shocowave lithotripsy is a noninvasive the urinary tract and may cause pain, bleeding, method of br

  10. Slide 10: Lithotripsy and Prostate Therapies

    HealthTronicss Lithotripsy and Prostate Therapies Provided on a mobile basis 90 Partnerships in over 40 States — 130+ Lithotripters — 55+ BPH Lasers — 25+ Cryo Units 70,000+ Lithotripsy and Prostate Procedures Performed Annually Treating at 500+ Hospitals and Surgery Centers Trusted Advisor to Urolo

  11. Slide 11: Geographic Mix

    <1 HealthTronicss Geographic Mix HealthTronics partnerships have a truly national presence with strong regional Presence in all the major markets throughout the United States . ° . ° Revenue by Region Partnership Distribution West 17% South ani Midwest Northeast 2%

  12. Slide 12: Prostate Cancer Market Data

    <1 HealthTronicss | Prostate Cancer Market Data - arget Indicatio ° Prostate Cancer + Cryabtation — Malignant growth of cellsin prostate gland ling GFomeer celts Eceldietibe > (Serie most Conminn career wi thelU.S.. — Over 20,000 procedures in the U.S.in 2009 : ADimlion Amencanines — Demand for foca

  13. Slide 13: HealthTronics

    HealthTronics lue : <Goak:Svortan te Gres to eatent of frst pale * Urologists maintain focus on providing care to patients while minimizing {or eliminating} the out-of- pocket expense related to regulatory and consolidation concerns + Health Tronics professional tearn leads ravigation through comple

  14. Slide 14: Anatomic Pathology

    SS) HealthTronicss | Anatomic Pathology Anatomic Pathology Market Overview ClariPath Strategy + The diagnois of cancer and other diseases through the oaamiration of tissues {hiopsies) and cells (cytology) + Requires the services of a pathologistto make a diagnosis. + Drivers include aging popubition

  15. Slide 15: Devices, Maintenance and Consumables

    HealthtTroni Devices, Maintenance and Consumables ¢ Conduit for New Technologies ° Products — Endocare Cryocare® CS for Cryoablation ¢ Fully integrated planning, placement and treatment system — Laser for BPH ¢ Acontinuous wave laser that interacts ideally with prostate tissue allowing precise vapor

  16. Slide 16: Acquisitions

    + Closed April 2008 for cash and stock totaling, «Closed in July 2008 for $7.5 million. approximately $15 million . i $ ed with “condo” « Leadingprovider of ntheus. Lstoricaly operate 25 2 urologist ovm coop + AMPListhe GP or managingmember in 25 phrysician partnerships servicing 46 states + Process

  17. Slide 17: Deal Overview

    ae PA 4 1 Deal Overview Deal dosed July 27% 2009 , Endocare now wholly owmed by HeakhTronics. ‘Total enterprise value of approximately $20 milion in stock, cash and assumed debt. Heath Tronics accounted for 40% of Endocare revenue following the 2008 AMP! acquisition. ‘Vertical acquisition that allow

  18. Slide 18: Diversification of Revenue

    HealthTronicss gs a: P’ Diversification of Revenue 2007 2008 July 2006 — Specialty Vehicles Divested, Debt paid dow) —_[ Api 2008 — AMP1 Acquired, HTRN Becomes lergest provider of Cryo services 2007 — ClarPath Labs First Full Year in Operation ‘Aug. 2008 — UroPath Acquired, Increased (Commitment to

  19. Slide 19: Specialties

    | > < HealthTronics Specialties aero ie Anatomic Pathology outside of Urology — Improves patient care «$1.8 billion non-hospital prostate : mesure — — Enhances practice economics market. including biling, accounting, HR, tax, Leverage Health Tronics networkto «Significant vabue added by HTRN executi

  20. Slide 20: HealthTronics Historical and Projected Financials

    -— yr y | 7 HealthTronicss | HealthTronics Historical and Projected Financials Sentech 2006 2007 2008 2009 201057 Revenue 142,891 140,418 165,942 185,323 205,500 Revenue Growth 6% Am 182% 17% 10.9% Adjusted Ema" 17,868 17,310 22,004 26,606 33,000 EBRDA® Rsk 123% Bas uae 16.1% [i Acjusted EBITD exclu

  21. Slide 21: Debt Position and Credit Facility

    <1 HealthTronicss | Debt Position and Credit Facility Health Tronics Historical Financials a meee 1231/2008 1278172009 Total Current Assets* 5489 58,003 Total Debt 46,387 48,519 New Credit Fai ined December 2009 + Strongrebtionships with our syndicate: JPMorgan Chase, Bank of America, Wachovia + $60

  22. Slide 22: End of Slides

    << = \ a ge” 4 HealthTronics [tL HealthTronics, Inc. End of Slides

HealthTronics — Investor Presentation (March 2010) on 6ix